Výsledky vyhledávání - "Dimitrios Kalafatis"

Akademický článek

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry

Autor: Jing Gao, Dimitrios Kalafatis, Lisa Carlson, Ida H. A. Pesonen, Chuan-Xing Li, Åsa Wheelock, Jesper M. Magnusson, C. Magnus Sköld

Publikováno v: Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)

Abstract Background Observational data under real-life conditions in idiopathic pulmonary fibrosis (IPF) is scarce. We explored anti-fibrotic treatment, disease severity and phenotypes in patients with IPF from the Swedish IPF Registry (SIPFR). Metho

Externí odkaz: https://doaj.org/article/69f748c5acc24d39ab251984584f4766

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden

Autor: Dimitrios Kalafatis, Jing Gao, Ida Pesonen, Lisa Carlson, C. Magnus Sköld, Giovanni Ferrara

Publikováno v: BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-8 (2019)

Abstract Background Idiopathic pulmonary fibrosis (IPF) is a disease with poor prognosis mainly affecting males. Differences in clinical presentation between genders may be important both for the diagnostic work-up and for follow-up. In the present s

Externí odkaz: https://doaj.org/article/ca3c7af037f64bfc9f978d567cccc835

Zobrazit plný text záznamu

Baseline characteristics and survival of patients of idiopathic pulmonary fibrosis: a longitudinal analysis of the Swedish IPF Registry

Autor: C. Magnus Sköld, Jesper Magnusson, Jing Gao, Åsa M. Wheelock, Lisa Carlson, Dimitrios Kalafatis, Chuanxing Li, Ida Pesonen

Publikováno v: Respiratory Research, Vol 22, Iss 1, Pp 1-13 (2021)
Respiratory Research

Background Observational data under real-life conditions in idiopathic pulmonary fibrosis (IPF) is scarce. We explored anti-fibrotic treatment, disease severity and phenotypes in patients with IPF from the Swedish IPF Registry (SIPFR). Methods Patien

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb5158300fe65c2f866981a7cb2b77b
https://doaj.org/article/69f748c5acc24d39ab251984584f4766

Zobrazit plný text záznamu

Plný text ve formátu HTML

Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis

Autor: Dimitrios Kalafatis, Anna Löfdahl, Per Näsman, Göran Dellgren, Åsa M. Wheelock, Linda Elowsson Rendin, Magnus Sköld, Gunilla Westergren-Thorsson

Publikováno v: International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 13421, p 13421 (2021)
International Journal of Molecular Sciences; Volume 22; Issue 24; Pages: 13421

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with an unmet need of biomarkers that can aid in the diagnostic and prognostic assessment of the disease and response to treatment. In this two-part explorative proteomic stud

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd4daaa6228f2b145fd3343dc81756e
https://pubmed.ncbi.nlm.nih.gov/34948231

Zobrazit plný text záznamu

Plný text ve formátu HTML

Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort

Autor: Michael T. Durheim, Tone Sjåheim, Charlotte Hyldgaard, Elisabeth Bendstrup, Marjukka Myllärniemi, Dimitrios Kalafatis, Lisa Carlson, Eva Sutinen, C. Magnus Sköld

Publikováno v: Durheim, M T, Bendstrup, E, Carlson, L, Sutinen, E M, Hyldgaard, C, Kalafatis, D, Myllärniemi, M, Sköld, C M & Sjåheim, T 2021, ' Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort ', Respirology, vol. 26, no. 10, pp. 982-988 . https://doi.org/10.1111/resp.14116

Background and objective: Antifibrotic therapy with nintedanib or pirfenidone slows disease progression and reduces mortality in patients with idiopathic pulmonary fibrosis (IPF). However, patients with advanced IPF, as defined by forced vital capaci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe986efb391d30ca7852dd64120de55
https://pure.au.dk/portal/da/publications/outcomes-of-patients-with-advanced-idiopathic-pulmonary-fibrosis-treated-with-nintedanib-or-pirfenidone-in-a-realworld-multicentre-cohort(06f0874b-070a-4c34-99cf-bfd164a23607).html